Table for the 6 triples with object "The FDA notes that this is a "moderate" CYP1A2 inhibitor in vivo in it most recent guidance document. See Table 6, p23" sorted by label

Subject	Predicate
?:evidence_1005	?:content
?:evidence_1062	?:content
?:evidence_1649	?:content
?:evidence_1699	?:content
?:evidence_1906	?:content
?:evidence_1958	?:content